Company intelligence / Profile preview
Cuda Pharmaceuticals
Douglaston, New York, United Statescudapharma.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Cuda Pharmaceuticals develops niche branded and generic pharmaceuticals with a focus on unique and limited access products. Its lead program centers on an improved formulation of the general anesthetic propofol, targeting a large market with historical supply issues. The company also pursues traditional generics, veterinary medicines, OTC drugs, NDA products, and specialty/complex formulations. No clinical results are publicly available as the main product remains in development.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Cuda Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cuda Pharmaceuticals.